![The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis - Mayo Clinic Proceedings The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis - Mayo Clinic Proceedings](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/8699a31d-3cf7-459d-a571-b015a16fde45/gr1_lrg.jpg)
The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis - Mayo Clinic Proceedings
![Integrating circulating-free DNA (cfDNA) analysis into clinical practice: opportunities and challenges | British Journal of Cancer Integrating circulating-free DNA (cfDNA) analysis into clinical practice: opportunities and challenges | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-022-01776-9/MediaObjects/41416_2022_1776_Fig1_HTML.png)
Integrating circulating-free DNA (cfDNA) analysis into clinical practice: opportunities and challenges | British Journal of Cancer
![Plasma-activated medium triggers cell death and the presentation of immune activating danger signals in melanoma and pancreatic cancer cells | Scientific Reports Plasma-activated medium triggers cell death and the presentation of immune activating danger signals in melanoma and pancreatic cancer cells | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-019-40637-z/MediaObjects/41598_2019_40637_Fig1_HTML.png)
Plasma-activated medium triggers cell death and the presentation of immune activating danger signals in melanoma and pancreatic cancer cells | Scientific Reports
![High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial - The Lancet Respiratory Medicine High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial - The Lancet Respiratory Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/960f9562-1f5d-4de2-9f10-524bc9567a87/gr1.gif)
High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial - The Lancet Respiratory Medicine
![The International Clinical Guideline for the Treatment of Vasculitis Got Published in the British Medical Journal-World-Class University Development Office The International Clinical Guideline for the Treatment of Vasculitis Got Published in the British Medical Journal-World-Class University Development Office](https://wudo.scu.edu.cn/__local/A/BC/EF/7242DA0C593237EE18A39501947_ACD8BDDD_3034A.png)